Physician profile
Daniel D Limb
NPI 1275021537
$1,866.94
in general payments reported to CMS, 2019-2025
9 companies · $374 in 2025
The $374 reported for 2025 was more than what 89% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $206 · 2023: $720 · 2024: $566 · 2025: $374.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,660.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,660.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $814.64 | 2023-2025 | Impella |
| Abbott Laboratories | $399.14 | 2022-2023 | Thoratec Heartmate 3 Lvas Implant Kit |
| Edwards Lifesciences Corporation | $206.91 | 2022-2023 | Hemosphere |
| Merck Sharp & Dohme LLC | $150.94 | 2023-2025 | Bridion |
| Baxter Healthcare | $145.30 | 2022-2025 | Perclot, Preveleak |
| Grifols USA, LLC | $53.61 | 2023 | Thrombate III |
| La Jolla Pharmaceutical Company | $47.91 | 2024-2025 | Giapreza |
| Eagle Pharmaceuticals, INC. | $28.87 | 2023 | |
| Fisher & Paykel Healthcare INC | $19.62 | 2025 | Fisher & Paykel Healthcare |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Limb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.